Literature DB >> 11162664

Regulation of fibronectin expression and splicing in migrating epithelial cells: migrating MDCK cells produce a lesser amount of, but more active, fibronectin.

T Inoue1, K Nabeshima, Y Shimao, J Y Meng, M Koono.   

Abstract

Previously we have demonstrated that in MDCK epithelial cells not only transforming growth factor-beta (TGF-beta) but also hepatocyte growth factor/scatter factor (HGF/SF) regulates fibronectin (FN) splicing by increasing the ratio of EDA-containing FN (EDA+ FN) mRNA to EDA-minus FN (EDA- FN) mRNA (EDA+/EDA- ratio). EDA+ FN is known to be upregulated in tissues where cells actively migrate, such as those during morphogenesis, wound healing, and tumorigenesis. However, a direct association between cell migration and FN splicing at the EDA region has never been investigated. In this work, we have shown by using an in vitro wound migration assay that migrating epithelial cells regulate FN production and splicing differently compared to nonmigrating cells. Wounds were introduced as migration stimuli into the 10-day-old confluent cell sheet, where the EDA+/EDA- ratio and FN mRNA expression levels were stable. In migrating cells at the wound edge, the FN mRNA level decreased by 0.73-fold and the EDA+/EDA- ratio increased by 1.32-fold when compared with nonmigrating cells apart from the wound edge. HGF/SF significantly stimulated cell migration at the wound edge and concomitantly decreased the FN mRNA level by 0.60-fold and increased the EDA+/EDA- ratio by 1.84-fold in migrating cells. In nonmigrating cells apart from the wound edge, FN mRNA expression and splicing were not influenced by either wound stimulation or HGF/SF. EDA+ FN stimulates cell migration more effectively than EDA- FN and thus is considered to be a more active variant of FN. Taken together, migrating MDCK cells appear to regulate FN mRNA expression and splicing to produce a lesser amount of, but more active, FN.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162664     DOI: 10.1006/bbrc.2001.4264

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  The α4β1 integrin and the EDA domain of fibronectin regulate a profibrotic phenotype in dermal fibroblasts.

Authors:  Arti V Shinde; Rhiannon Kelsh; John H Peters; Kiyotoshi Sekiguchi; Livingston Van De Water; Paula J McKeown-Longo
Journal:  Matrix Biol       Date:  2014-11-26       Impact factor: 11.583

2.  Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.

Authors:  Abby L Olsen; Bridget K Sackey; Cezary Marcinkiewicz; David Boettiger; Rebecca G Wells
Journal:  Gastroenterology       Date:  2011-12-24       Impact factor: 22.682

3.  An essential role for fibronectin extra type III domain A in pulmonary fibrosis.

Authors:  Andrés F Muro; Federico A Moretti; Bethany B Moore; Mei Yan; Rachelle G Atrasz; Carol A Wilke; Kevin R Flaherty; Fernando J Martinez; Jessica L Tsui; Dean Sheppard; Francisco E Baralle; Galen B Toews; Eric S White
Journal:  Am J Respir Crit Care Med       Date:  2007-12-20       Impact factor: 21.405

4.  Investigation of human embryonic stem cell-derived keratinocytes as an in vitro research model for mechanical stress dynamic response.

Authors:  Thibaud Cherbuin; Mohammad Mehdi Movahednia; Wei Seong Toh; Tong Cao
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

5.  Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma.

Authors:  Kristoffer Larsen; Johan Malmström; Marie Wildt; Camilla Dahlqvist; Lennart Hansson; György Marko-Varga; Leif Bjermer; Agneta Scheja; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2006-01-23

6.  Propolis modulates fibronectin expression in the matrix of thermal injury.

Authors:  Pawel Olczyk; Katarzyna Komosinska-Vassev; Grzegorz Wisowski; Lukasz Mencner; Jerzy Stojko; Ewa M Kozma
Journal:  Biomed Res Int       Date:  2014-03-11       Impact factor: 3.411

Review 7.  The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine.

Authors:  B Eyden
Journal:  J Cell Mol Med       Date:  2007-12-22       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.